Welcome to our dedicated page for Macy's SEC filings (Ticker: M), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Macy’s, Inc. filings document the public-company disclosures of a retail operator with the Macy’s, Bloomingdale’s and Bluemercury nameplates. Recent Form 8-K reports cover operating results, financial condition, cash flows, non-GAAP measures such as adjusted EBITDA and adjusted earnings, and updates to financial disclosure metrics tied to the company’s go-forward business and comparable-sales reporting.
The company’s proxy and other current reports also describe shareholder meeting matters, board composition, director elections, executive compensation, compensatory arrangements and governance changes. These filings frame Macy’s capital-market reporting around retail performance, disclosure controls, governance structure and shareholder voting processes.
Macy's, Inc. SVP and Controller Paul Griscom reported routine equity compensation activity. On March 31, 2026, he exercised 1,715 restricted stock units, receiving the same number of common shares at a conversion price of $0.00 per share.
On April 1, 2026, he sold 490 common shares at a weighted average price of $18.0757 per share to cover tax withholding obligations upon the vesting of restricted shares, which the filing notes was not a discretionary transaction. After these transactions, he directly holds 33,566 common shares and 1,716 restricted stock units.
Macy's, Inc. executive vice president and chief HR officer Danielle L. Kirgan reported routine equity compensation activity. On March 31, 2026, 12,864 restricted stock units converted into an equal number of common shares at a conversion price of $0.00 per share. Footnotes state each restricted stock unit equals one share of common stock and that these units were part of a grant made on March 31, 2023, vesting in four equal installments.
On April 1, 2026, she sold 6,573 common shares at a weighted average price of $18.0766 per share to cover tax withholding obligations upon vesting, which the disclosure notes was not a discretionary transaction. Following these events, she directly holds 98,299 shares of common stock and 12,865 restricted stock units.
Macy's, Inc. Chairman & CEO Antony Spring reported routine equity compensation activity. He exercised restricted stock units into 28,588 shares of common stock at a conversion price of $0.00 per share. On the following day, he sold 14,606 shares at a weighted average price of $18.0765 per share solely to cover tax withholding obligations, which the filing notes was not a discretionary transaction. After these moves, he directly holds about 437,238 shares of Macy's common stock.
Macy's, Inc. director Douglas William Sesler received a grant of 1,366 Phantom Stock Units, each with a reference value of $20.1234. These units have a 1-for-1 conversion into common stock and will be settled in Macy's common shares when he leaves the Board of Directors. Following this compensation grant, he holds 1,366 phantom units linked to an equal number of common shares.
MARKEE RICHARD L reported acquisition or exercise transactions in this Form 4 filing.
Macy's, Inc. director Richard L. Markee received a grant of 1,366 Phantom Stock Units, each convertible 1-for-1 into Common Stock. The units are valued at an average of $20.1234 per unit and will be settled in Common Stock when he leaves the Board of Directors, bringing his total Phantom Stock Units to 1,366.
Macy's, Inc. director Richard Clark received a grant of 1,366 Phantom Stock Units tied to the company’s Common Stock. These units convert on a 1-for-1 basis into shares of Common Stock and are scheduled to be settled in stock when he leaves the Board of Directors.
The units were valued at an average of $20.1234 per unit for this quarterly grant period, bringing Clark’s total reported Phantom Stock Units to 1,366 held directly after the award. This is a compensation-related, non-cash equity grant rather than an open-market purchase.
Macy's, Inc. filed a Form 144 reporting a proposed sale of 1,715 shares of Common Stock tied to restricted stock vesting on 03/31/2026, to be transacted through Charles Schwab & Co. The filing also lists three recent dispositions: 379 shares on 03/25/2026 for $7,105.96, 2,919 shares on 03/27/2026 for $52,303.74, and 433 shares on 03/30/2026 for $7,683.16.
Macy's, Inc. submitted a Form 144 notice related to Common Stock tied to a Restricted Stock Vesting event dated 03/31/2026. The filing lists 12,864 shares associated with the vesting and shows prior open‑market sales by Danielle L. Kirgan: 3,047 shares on 03/25/2026 for $57,031.70, 15,415 shares on 03/27/2026 for $276,125.65, and 5,161 shares on 03/30/2026 for $91,515.98. The header shows 263,739,490 shares with an associated date of 04/01/2026.
Macy's, Inc. filed a Form 144 notice reporting a proposed sale of 28,588 shares of Common Stock through Charles Schwab, with an indicated aggregate value of $517,156.92 and execution on 04/01/2026 on the NYSE. The filing notes these shares arise from restricted stock vesting dated 03/31/2026 and lists recent dispositions in March 2026 totaling 71, - 925 shares (examples: 41,450 shares sold for $742,455.78 on 03/27/2026). Shares outstanding are shown as 263,739,490 as of 04/01/2026.
Macy's, Inc. senior vice president and controller Paul Griscom reported a combination of equity vesting and a small share sale. On March 28, 2026, 1,501 restricted stock units converted into the same number of common shares at a conversion price of $0.00 per share.
On March 30, 2026, he sold 433 shares of common stock at a weighted average price of $17.744 per share to cover tax withholding obligations upon the vesting of restricted shares, which the filing states was not a discretionary transaction. After these transactions, he directly owned 32,341 shares of Macy's common stock.